Study Finds People Living With Lung Cancer Are Too Often Stigmatized Because Of Link To Smoking
Washington, DC [July 13, 2010] —Today,
Lung Cancer Alliance (LCA) highlighted a study, carried out by Ipsos
MORI on behalf of The Global Lung Cancer Coalition (GLCC). The study
finds lung cancer patients are likely to suffer significant stigma due
to the disease’s link to smoking.
Over 16,000 people in 16 countries were asked questions
about their attitudes surrounding lung cancer. The study found some
evidence that sympathy levels were influenced by the smoking rates of
each country. Generally people in countries with lower smoking rates
had a greater tendency to admit that they felt less sympathetic to
people with lung cancer compared with other types of cancer.
Lung cancer is the leading cause of cancer death in the
United States and worldwide. This year it will take the lives of
nearly twice as many women as breast cancer and three times as many men
as prostate cancer. At least two thirds of those diagnosed are
former smokers or those who have never smoked.
“This study reinforces what the lung cancer community
has felt for decades—public perception of this disease is
overwhelmingly negative,” said Laurie Fenton Ambrose, LCA President
& CEO. “We must do more to overcome this pervasive stigma and
focus attention where it should be—on research for early detection and
treatment for lung cancer. Lung cancer patients deserve the same
compassion and support given to those impacted by other diseases.”
The report found significant variation between
countries. The range of responses of adults went from 10-29%, with the
United States falling above average, and on a par with Canada at 22%
expressing less sympathy for people with lung cancer than people with
other kinds of cancer.
To learn more about the survey, please contact Emma Gunby on +44151 254 7210/+447505 834 356 or email@example.com. The report can also be downloaded from www.lungcancercoalition.org.
The Global Lung Cancer Coalition, www.lungcancercoalition.org,
is an international group of 26 patient organizations dedicated to
supporting the needs of lung cancer patients. It is the first truly
international patient alliance to promote global understanding of the
burden of lung cancer and the rights of patients to effective early
detection, better treatment and supportive care. By serving as the
international voice of lung cancer patients, the GLCC is committed to
improving disease outcomes for all.